<!DOCTYPE html>
<html>

<head>
	<link href="https://fonts.googleapis.com/css?family=Josefin+Sans&display=swap" rel="stylesheet" />	
	<link href="https://fonts.googleapis.com/css?family=Fira+Mono&display=swap" rel="stylesheet" />
	<link href="https://fonts.googleapis.com/css?family=Abril+Fatface&display=swap" rel="stylesheet" /><link href="./css/main.css" rel="stylesheet" />
	<link href="https://fonts.googleapis.com/css2?family=Fira+Mono:wght@700&display=swap" rel="stylesheet">
	<link href="https://fonts.googleapis.com/css2?family=Fira+Mono:wght@500;700&display=swap" rel="stylesheet">

	<meta name ="viewport" content = "width=device-width, initial-scale=1">


<title>curriculum vitae</title>
</head>

<body>
	<div class="sidebar">
	  <a class="about me" href="index.html">about</a>
	  <a class="research" href="research.html">research</a>
	  <a class="resume" href="resume.html">CV</a>

	</div>
	
	<div class="container_research">
		<h1>curriculum vitae</h1>
		
		<h2>education</h2>
		<h3>Yale School of Medicine</h3>
			<p> 
				M.D. Candidate (Expected Graduation: May 2024)<br>
				George D. Gross M.D. Scholarship<br>
			</p>
		<h3>Columbia University</h3>
			<p> 
				B.A. Chemical Physics, Concentration in Biology<br>
				John Jay Scholar
			</p>

		<h2>industry</h2>
		<h3>ClearView Healthcare Partners</h3>
			<p> 
				Analyst<br>
				Aug. 2018 - Aug. 2019<br><br>
				ClearView is a strategy consulting firm focused exclusively on the life sciences industry. Select prior project experience includes:<br>
				<ul>
					<li>Acquisition strategy for private equity firm aiming to develop a health-tech data analytics company</li>
					<li>Corporate valuation for oncology biotech</li>
					<li>Disruptive pricing & market access trends analysis for large biotech</li>
					<li>Lifecycle management strategy in pulmonary medicine space for specialty pharmaceutical firm</li>
					<li>Growth strategy in neurology for large biotech</li>			
				</ul>
			</p>

		<h2>research</h2>
		<h3>Solomon Center for Health Law and Policy</h3>
			<p> 
			Fellow<br>
			Yale School of Medicine and Yale Law School<br>
			Oct. 2019 - Present<br>
			<ul>
					<li>Researching how the law impacts emerging medical technologies, through policy analysis and epidemiological studies.</li>
					<li>Previous research papers have focused on health data privacy, diagnostic testing, innovation policy, and real-world evidence</li>
				</ul>
			</p>
		<h3>Program on Regulation, Therapeutics, and Law</h3>
			<p> 
				Student Researcher<br>
				Harvard Medical School and Brigham and Women’s Hospital<br>
				June 2020 - Present<br>
				<ul>
					<li>Researching postmarketing studies issued by the Food and Drug Administration.</li>	
				</ul>
			</p>
		<h3>Department of Biostatistics</h3>
			<p> 
			Student Researcher<br>
			Yale School of Medicine and Yale School of Public Health<br>
			Jan. 2020 - Dec. 2021<br>
				<ul>
					<li>Researched cancer immunogenomics using statistical modeling and computational methods</li>
					<li>Created a mathematical model to characterize phenomenon in cancer immunology</li>
					<li>Constructed an analysis pipeline in Python and R processing ~50 GB of empirical genetic data to validate mathematical model</li>
				</ul>
			</p>
		<h3>Department of Chemistry, Department of Physics</h3>
			<p> 
			Student Researcher<br>
			Columbia University<br>
			Jan. 2015 - May 2018<br>
				<ul>
					<li>Researched in Xiaoyang Zhu’s experimental and theoretical physical chemistry group on photophysics of novel materials</li>
				</ul>
			</p>


		<h2>recent service</h2>
		<h3>Scrubs Addressing the Firearm Epidemic (SAFE)</h3>
			<p> 
			Organization Leader<br>
			<ul>
				<li>Leading the Yale campus chapter for a national organization focused on eliminating the public health threat of firearm violence.</li>
			</ul>
		</p>

		<h3>Committee for Diversity, Inclusion and Social Justice</h3>				
		<p> 
			Committee Member<br>
			<ul>
				<li> Advocating for health equity at the institutional level by serving on a committee of students and faculty chaired by the Dean of the School of Medicine. The committee seeks to establish sustainable reform to increase diversity, foster an inclusive environment, and advance social justice.</li>
			</ul>
			</p>

		<h3>Dwight Community Management Team</h3>
		<p> 
			Committee Member<br>
			<ul>
				<li>Served on the local New Haven neighborhood management team to advocate for better community health outcomes.</li>
				<li>Led a project to install air quality monitors in the neighborhood. </li>
				<li>Created a community health profile by scraping public health data to characterize neighborhood-specific disease incidences.</li>
			</ul>
		</p>

		<h2>teaching</h2>
		<h3>FDA Law and Policy</h3>
			<ul>
				<li>Yale Law School</li>
				<li>Spring 2022</li>
				<li>Teaching Assistant</li>
			</ul>
		<h3>Organic Chemistry Lab</h3>
			<ul>
				<li>Columbia University</li>
				<li>Summer 2017</li>
				<li>Teaching Assistant</li>
			</ul>
		<h3>Physical Chemistry</h3>
			<ul>
				<li>Columbia University</li>
				<li>Fall 2017, Spring 2018</li>
				<li>Chemistry Department Teaching Assistant</li>
			</ul>
		<h3>Organic Chemistry</h3>
			<ul>
				<li>Columbia University</li>
				<li>Fall 2017, Spring 2018</li>
				<li>Chemistry Department Teaching Assistant</li>
			</ul>
		<h3>General Chemistry</h3>
			<ul>
				<li>Columbia University</li>
				<li>Summer 2017, Fall 2017, Spring 2018</li>
				<li>Teaching Assistant (for individual course and department)</li>
			</ul>

		<h2>publications</h2>
		<h5>
			8. Generating evidence during a pandemic: what’s reliable?
		</h5>
		<p> 
			<ul style="list-style: none;">
				<li><u>The BMJ</u>   <a href="https://www.bmj.com/content/377/bmj.o1229">[DOI]</a>  <a href="PDFs/Wallach_BMJ_2022.pdf"> [PDF]</a> <br></li>
				<li>May 2022</li>
				<li>Wallach JD, <span class = "name">Moneer O</span>, Ross JS. <br></li>
			</ul>
		</p>

 		<h5>
			7. Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study.
		</h5>
		<p> 
			<ul style="list-style: none;">
				<li><u>The BMJ</u>   <a href="https://www.bmj.com/content/377/bmj-2021-069400.full">[DOI]</a>  <a href="PDFs/Moneer_BMJ_2022.pdf"> [PDF]</a> <br></li>
				<li>May 2022</li>
				<li><span class = "name">Moneer O</span>, Daly G, Skydel JJ, Nyhan K, Lurie P, Ross JS, Wallach JD. <br></li>
			</ul>
		</p>

		<h5>
			6. New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the Evidence.
		</h5>
		<p> 
			<ul style="list-style: none;">
				<li><u>Drug Safety</u>   <a href="https://doi.org/10.1007/s40264-022-01152-9">[DOI]</a>  <a href="PDFs/Moneer_DrugSafety_2022.pdf"> [PDF]</a> <br></li>
				<li>February 2022</li>
				<li><span class = "name">Moneer O</span>, Brown BL, Avorn J, Darrow JJ, Mitra-Majumdar M, Joyce KW, Ross M, Pham C, Kesselheim AS. <br></li>
			</ul>
		</p>

<!-- 		<h2>2021</h2>
 -->
		<h5>
			5. Direct-to-consumer personal genomic tests need better regulation.
		</h5>
		<p> 
		<ul style="list-style: none;">	
			<li><u>Nature Medicine</u>   <a href = "https://doi.org/10.1038/s41591-021-01368-9"> [DOI]</a> <a href="PDFs/Moneer_Nature-Med_2021.pdf">[PDF]</a> <br></li>
			<li>June 2021</li>
			<li><span class = "name">Moneer O</span>, Miller JE, Shah ND, Ross JS. <br></li>
		</ul>


		</p>

		<h5>
			4. Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020.
		</h5>
		<p> 
		<ul style="list-style: none;">	
			<li><u>JAMA Network Open</u>  <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2779381">[DOI]</a> <a href="PDFs/Moneer_JAMA-NO_2021.pdf">[PDF]</a> <br></li>
			<li> April 2021</li>
			<span class = "name">Moneer O</span>, Lee CC, Avorn J, Kesselheim AS.<br> </li>
			</ul>
		</p>


		<h5>
			3. An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19. 
		</h5>
		<p> 
		<ul style="list-style: none;">	
			<li><u>Health Affairs</u> <a href= "https://doi.org/10.1001/jamanetworkopen.2021.8530">[DOI]</a> <a href="PDFs/Kesselheim_HA_2020.pdf">[PDF]</a>  <br></li>
			<li>January 2021 </li>
			<li>Kesselheim AS, Darrow JJ, Kulldorff M, Brown BL, Mitra-Majumdar M, Lee CC, <span class = "name">Moneer O</span>, Avorn J. <br></li>
		</ul>
		</p>

<!-- 		<h2>2020</h2>
 -->		<h5>
			2. Covid-19, single-sourced diagnostic tests, and innovation policy. 
		</h5>
		<p>
			<ul style="list-style: none;">	
				<li><u>Journal of Law and Biosciences</u> <a href= "https://doi.org/10.1093/jlb/lsaa053">[DOI]</a> <a href="PDFs/Deb-Moneer_JLB_2020.pdf">[PDF]</a> <br></li>
				<li>July 2020</li>
				<li>*<span class = "name">Moneer O</span>, *Deb C, Price WN 2nd. <br></li>
				<li><i>*denotes equal author contributions</i></li>
			</ul>
		</p>

<!-- 		<h2>undergraduate</h2>
 -->	<h5> 
			1. Electrostatic screening of charged defects in monolayer MoS2. 
		</h5>
		<p> 
			<ul style="list-style: none;">	
				<li><u>Journal of Physical Chemistry Letters</u> <a href ="https://doi.org/10.1021/acs.jpclett.7b00710">[DOI]</a> <a href="PDFs/Atallah-JPC-Letters_2017.pdf">[PDF]</a> <br></li>
				<li>May 2017</li> 
				<li>Atallah TL, Wang J, Bosch M, Seo D, Burke RA, <span class = "name">Moneer O</span>, Zhu J, Theibault M, Brus LE, Hone J, Zhu XY. <br></li>
			</ul>
			
		</p>
		
		<h2>conferences and presentations</h2>
		
		<h5>
			Agreement of treatment effects estimates from observational studies and RCTs evaluating therapeutics for COVID-19
		</h5>
		<p> 
			<ul style="list-style: none;">
				<li><u>Peer Review Congress</u>  <a href="PDFs/Moneer_PRC_Abstract_2022.pdf">[Abstract]</a>  <a href="PDFs/Moneer_PRC_Poster_2022.pdf"> [Poster]</a> <br></li>
				<li>September 2022 (forthcoming)</li>
				<li>Moneer O, Daly G, Skydel JJ, Nyhan K, Lurie P, Ross JS, Wallach JD. <br></li>
			</ul>
		</p>
		<p> <br> <br> <br> </p>



	</div>

	

</body>

</html>